TY - JOUR
T1 - Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure
AU - Florea, Viorel G.
AU - Henein, Michael Y.
AU - Cicoira, Mariantonietta
AU - Anker, Stefan D.
AU - Doehner, Wolfram
AU - Ponikowski, Piotr
AU - Francis, Darrel P.
AU - Gibson, Derek G.
AU - Coats, Andrew J.S.
N1 - Funding Information:
Dr. Florea was supported by a research fellowship from the European Society of Cardiology. Professor Coats is sponsored by the Viscount Royston Trust, London, United Kingdom.
PY - 2000/7
Y1 - 2000/7
N2 - This study sought to assess the prognostic significance of echocardiographic measurements of left and right ventricular dimensions and function in patients >67 years of age with chronic congestive heart failure (CHF). This is a retrospective follow-up of elderly patients who underwent an echocardiography in the tertiary cardiac center. A total of 185 patients (131 men) aged ≥68 years (mean ± SD 75 ± 5) with CHF were enrolled into the study. After undergoing a detailed echocardiographic examination, all patients were followed-up for a median of 20 months (interquartile range 9 to 36). During the follow-up period 54 patients (29%) died. Left ventricular (LV) M-mode isovolumic relaxation time (IVRT), end-diastolic and end-systolic diameters, fractional shortening and mass, transmitral E:A ratio, and left atrial dimension, as well as New York Heart Association class and the age were found by Cox proportional-hazards univariate analyses to predict the outcome in these patients (all p <0.05). In multivariate analyses including these measurements, LV IVRT (p <0.04), age (p <0.03), and New York Heart Association class (p <0.001) were found to be the independent predictors of outcome. In the Kaplan-Meier analysis, patients with LV IVRT >30 ms had a better prognosis at 3 years (cumulative survival 78% [95% confidence interval 65% to 91%]) than those with LV IVRT ≤30 ms (survival 52% [95% confidence interval 37% to 68%]). Measurements of LV performance, especially those obtained during diastole, are significantly related to prognosis in patients >67 years of age with CHF. LV M-mode IVRT is among the most important independent predictors of outcome in this population. Copyright (C) 2000 Excerpta Medica Inc.
AB - This study sought to assess the prognostic significance of echocardiographic measurements of left and right ventricular dimensions and function in patients >67 years of age with chronic congestive heart failure (CHF). This is a retrospective follow-up of elderly patients who underwent an echocardiography in the tertiary cardiac center. A total of 185 patients (131 men) aged ≥68 years (mean ± SD 75 ± 5) with CHF were enrolled into the study. After undergoing a detailed echocardiographic examination, all patients were followed-up for a median of 20 months (interquartile range 9 to 36). During the follow-up period 54 patients (29%) died. Left ventricular (LV) M-mode isovolumic relaxation time (IVRT), end-diastolic and end-systolic diameters, fractional shortening and mass, transmitral E:A ratio, and left atrial dimension, as well as New York Heart Association class and the age were found by Cox proportional-hazards univariate analyses to predict the outcome in these patients (all p <0.05). In multivariate analyses including these measurements, LV IVRT (p <0.04), age (p <0.03), and New York Heart Association class (p <0.001) were found to be the independent predictors of outcome. In the Kaplan-Meier analysis, patients with LV IVRT >30 ms had a better prognosis at 3 years (cumulative survival 78% [95% confidence interval 65% to 91%]) than those with LV IVRT ≤30 ms (survival 52% [95% confidence interval 37% to 68%]). Measurements of LV performance, especially those obtained during diastole, are significantly related to prognosis in patients >67 years of age with CHF. LV M-mode IVRT is among the most important independent predictors of outcome in this population. Copyright (C) 2000 Excerpta Medica Inc.
UR - http://www.scopus.com/inward/record.url?scp=0034124484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034124484&partnerID=8YFLogxK
U2 - 10.1016/S0002-9149(00)00853-5
DO - 10.1016/S0002-9149(00)00853-5
M3 - Article
C2 - 10913476
AN - SCOPUS:0034124484
SN - 0002-9149
VL - 86
SP - 158
EP - 161
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 2
ER -